Skip to main content
. 2021 May 6;15(5):e0009190. doi: 10.1371/journal.pntd.0009190

Table 1. Vaccine trials for WNV.

VACCINES
Title NCT Number Dates Phase Status Interventions Number Enrolled Sponsor/ Collaborators Publications
Safety of and Immune Response to a West Nile Virus Vaccine (WN/DEN4-3’delta30) in Healthy Adults NCT00094718 Posted: 10/22/2004 Completed: 4/2005 1 Completed WN/DEN4-3’delta30 vs Placebo (vaccine diluent) 56 Johns Hopkins Bloomberg School of Public Health, NIAID* PMID: 23968769
Safety of and Immune Response to a West Nile Virus Vaccine (WN/DEN4delta30) in Healthy Adults NCT00537147 Posted: 9/28/2007 Completed: 6/2009 1 Completed WN/DEN4delta30 vs Placebo (vaccine diluent) 26 Johns Hopkins Bloomberg School of Public Health, NIAID*
Evaluating the Safety and Immunogenicity of a Live Attenuated West Nile Virus Vaccine for West Nile Encephalitis in Adults 50 to 65 Years of Age NCT02186626 Posted: 7/10/2014 Completed: 7/2016 1 Completed WN/DEN4delta30 vs Placebo (vaccine diluent) 28 NIAID* PMID: 28077583
Vaccine to Prevent West Nile Virus Disease NCT00106769 Posted: 3/30/2005Completed: 1/15/2008 1 Completed VRC-WNVDNA017-00-VP 15 National Institutes of Health Clinical Center, NIAID* PMID: 18190252
Phase I Study of West Nile Virus Vaccine NCT00300417 Posted: 3/8/2006 Completed: 12/28/2007 1 Completed VRC-WNVDNA020-00-VP 30 National Institutes of Health Clinical Center, NIAID* PMID: 21398392
Safety and Immunogenicity of ChimeriVax-WN02 West Nile Vaccine in Healthy Adults NCT00442169 Posted: 3/1/2007 Completed: 4/2009 2 Completed ChimeriVax-WN02 vs Placebo (normal saline) 208 Sanofi Pasteur PMID: 21148499
Safety and Immunogenicity Study of ChimeriVax West Nile Vaccine in Healthy Adults NCT00746798 Posted: 9/4/2008 Completed: 12/2009 2 Completed ChimeriVax-WN02 vs Placebo (normal saline) 479 Sanofi Pasteur PMID: 22959989
Safety Study of HBV-002 West Nile Vaccine in Healthy Adults NCT00707642 Posted: 7/1/2008 Completed: 6/2009 1 Completed WN-80E 25 Hawaii Biotech, Inc Patent listing: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=10039820.PN.&OS=PN/10039820&RS=PN/10039820
Phase 1 Trial of Inactivated West Nile Virus Vaccine NCT02337868 Posted: 1/14/2015 Completed: 12/16/2016 1 Completed HydroVax-001 vs Placebo 96 NIAID* PMID: 30661836

*NIAID, National Institute of Allergy and Infectious Diseases.

WNV, West Nile virus.